Literature DB >> 12058643

Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.

W Ripley Ballou1, Kent E Kester, D Gray Heppner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12058643

Source DB:  PubMed          Journal:  Chem Immunol        ISSN: 0079-6034


× No keyword cloud information.
  1 in total

1.  A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.

Authors:  Alphonse Ouédraogo; Alfred B Tiono; Désiré Kargougou; Jean Baptiste Yaro; Esperance Ouédraogo; Youssouf Kaboré; David Kangoye; Edith C Bougouma; Adama Gansane; Noelie Henri; Amidou Diarra; Souleymane Sanon; Issiaka Soulama; Amadou T Konate; Nora L Watson; Valerie Brown; Jenny Hendriks; Maria Grazia Pau; Isabella Versteege; Edison Wiesken; Jerald Sadoff; Issa Nebie; Sodiomon B Sirima
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.